Not yet recruitingPHASE2, PHASE3NCT07016321

Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)

Studying Dengue fever

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Johns Hopkins University
Principal Investigator
Kunchok Dorjee, MBBS, PhD
Johns Hopkins University
Intervention
Emetine Hydrochloride 6mg(drug)
Enrollment
600 enrolled
Eligibility
18-65 years · All sexes
Timeline
20262029

Study locations (2)

Collaborators

Bharatpur Hospital Chitwan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07016321 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever

← Back to all trials